Forte Biosciences
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $38 |
Gross Profit | -17 | -15 | -13 | -10 |
EBITDA | -17,665 | -11,564 | -16,111 | -7,145 |
EBIT | -17,682 | -11,579 | -16,124 | -7,155 |
Net Income | -17,682 | -11,249 | -15,656 | -7,155 |
Net Change In Cash | 0 | 0 | 0 | 38 |
Free Cash Flow | -14,055 | -10,061 | -10,416 | -10,040 |
Cash | 93,414 | 106,144 | 45,856 | 22,244 |
Basic Shares | 17,793 | 11,744 | 11,398 | 6,393 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -39 | -9 | -36 | |
EBITDA | -35,439 | -32,476 | -13,896 | -21,450 |
EBIT | -35,478 | -32,485 | -13,896 | -21,486 |
Net Income | -35,478 | -31,476 | -13,862 | -21,708 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -30,782 | -28,794 | -8,185 | -16,677 |
Cash | 22,244 | 11,961 | 41,100 | 42,044 |
Basic Shares | 2,915 | 1,262 | 695 | 558 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.99 |
2025-06-30 | -$0.96 |
2025-03-31 | -$1.37 |
2024-12-31 | -$1.17 |
